Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death-Reference-Cited by-同舟云学术

Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death

Published:2019-05-13 Issue:5 Volume:14 Page:e0211090
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Reddy Vidyavathi,Iskander Asm,Hwang Clara,Divine George,Menon Mani,Barrack Evelyn R.,Reddy G. Prem-Veer,Kim Sahn-Ho^ORCID

Funder

Department of Defense Prostate Cancer Research Program

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Abiraterone and increased survival in metastatic prostate cancer;JS de Bono;The New England journal of medicine,2011

2. Increased survival with enzalutamide in prostate cancer after chemotherapy;HI Scher;The New England journal of medicine,2012

3. The development of androgen-independent prostate cancer;BJ Feldman;Nature reviews Cancer,2001

4. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells;P Haag;J Steroid Biochem Mol Biol,2005

5. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors. Clinical cancer research: an official journal of the;R Snoek;American Association for Cancer Research,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetylated KHSRP impairs DNA‐damage‐response‐related mRNA decay and facilitates prostate cancer tumorigenesis;Molecular Oncology;2024-03-19

2. A Novel Role of Prostate-Specific Membrane Antigen in Telomere Stability in Prostate Cancer Cells;Molecular Cancer Research;2023-08-09

3. Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC;Frontiers in Oncology;2023-06-30

4. Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancer;2023-04-25

5. Androgen Receptor Upregulates Mucosa-Associated Lymphoid Tissue 1 to Induce NF-κB Activity via Androgen-Dependent and -Independent Pathways in Prostate Carcinoma Cells;International Journal of Molecular Sciences;2023-03-26